ImmunoScape fetches $14m

ImmunoScape, a provider of an immunomics-based technology platform, has secured $14 million in funding.

ImmunoScape, a provider of an immunomics-based technology platform, has secured $14 million in funding. The investors included Anzu Partners, University of Tokyo Edge Capital Partners and EDBI.

Source: Press Release